These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1267442)

  • 21. Use of penicillinase-resistant penicillins to increase the susceptibility of gram-negative bacteria to antibiotics.
    Farrar WE; O'Dell NM; Krause JM
    Ann Intern Med; 1967 Oct; 67(4):733-43. PubMed ID: 4862467
    [No Abstract]   [Full Text] [Related]  

  • 22. Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species.
    Trestman I; Kaye D; Levison ME
    Antimicrob Agents Chemother; 1979 Sep; 16(3):283-6. PubMed ID: 228593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergy of vancomycin with penicillins and cephalosporins against pseudomonas, klebsiella, and serratia.
    Donabedian H; Andriole VT
    Yale J Biol Med; 1977; 50(2):165-76. PubMed ID: 408984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of cefazolin against recent clinical bacterial isolates.
    Sabath LD; Wilcox C; Garner C; Finland M
    J Infect Dis; 1973 Oct; 128():Suppl:S320-6. PubMed ID: 4200651
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sensitivity of clinical Proteus strains to antibiotics and their combinations].
    Sheina EP; Arutcheva AA
    Antibiotiki; 1978 May; 23(5):424-8. PubMed ID: 350143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.
    Kuck NA; Testa RT; Forbes M
    Antimicrob Agents Chemother; 1981 Apr; 19(4):634-8. PubMed ID: 6454388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of antibiotic sensitivities of gram-negative bacilli (comparison of single-disc and inocula-replicating methods).
    Klastersky J; Debusscher L; Cappel R; Swings G; Daneau D
    Rev Eur Etud Clin Biol; 1971 Apr; 16(4):391-4. PubMed ID: 4327597
    [No Abstract]   [Full Text] [Related]  

  • 30. Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
    Neu HC
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():43-52. PubMed ID: 893247
    [No Abstract]   [Full Text] [Related]  

  • 31. Penicillins and cephalosporins: differences in morphologic effects on Proteus mirabilis.
    Lorain V; Sabath LD
    J Infect Dis; 1972 May; 125(5):560-4. PubMed ID: 4554111
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro action of carbenicillin against bacteria isolated from clinical material.
    Isenberg HD; Siegel M
    Appl Microbiol; 1969 Sep; 18(3):387-92. PubMed ID: 4392088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci.
    Thabaut A; Durosoir JL; Saliou P
    Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
    Schassan HH
    Infection; 1979; 7 Suppl 6():527-31. PubMed ID: 399243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.
    Isenberg HD; Sampson-Scherer J; Cleeland R; Titsworth E; Beskid G; Christenson JG; DeLorenzo WF; Unowsky J
    Crit Rev Microbiol; 1982; 10(1):1-76. PubMed ID: 6756787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.
    Neu HC
    Antimicrob Agents Chemother; 1976 May; 9(5):793-9. PubMed ID: 949176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of penicillins and cephalosporins to beta-lactamases from Gram-negative bacilli: some correlations with antibacterial activity.
    Sabath LD; Finland M
    Ann N Y Acad Sci; 1967 Sep; 145(2):237-47. PubMed ID: 4998177
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study on the antibacterial activity of penicillins and cephalosporines in urine (author's transl)].
    Shah PM; Schirmer KP; Helm EB; Stille W
    Arzneimittelforschung; 1976; 26(9):1636-8. PubMed ID: 826261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.